Levosimendan Impurity 6
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Levosimendan Impurity 6 Product Information
Levosimendan Impurity 6 is listed under Impurity and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Levosimendan. The product is supplied by Clearsynth under CAT No. CS-O-31731.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Levosimendan Impurity 6
CAS No.
36725-28-7
CAT No.
CS-O-31731
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C11H13N3O
Molecular Weight
203.24
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Levosimendan Impurity 6 is supplied with detailed characterization data compliant with regulatory guideline. Levosimendan Impurity 6 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Levosimendan.
Overview
AMDP3 (4-Aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one) acts as a cardiac troponin effecter, resulting in activation of cardiac muscle contractions. It's an analogue to Levosimendan , positive inotropic agent with vasodilating activity.
Synonyms
Levosimendan Impurity 6
Application Notes
AMDP3 (4-Aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one) acts as a cardiac troponin effecter, resulting in activation of cardiac muscle contractions. It's an analogue to Levosimendan , positive inotropic agent with vasodilating activity.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.